- Home
- CELC vs CXT Comparison
CELC vs CXT Comparison
Compare CELC & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CXT
- Stock Information
- Founded
- CELC 2011
- CXT 1855
- Country
- CELC United States
- CXT United States
- Employees
- CELC N/A
- CXT N/A
- Industry
- CELC Medical Specialities
- CXT Office Equipment/Supplies/Services
- Sector
- CELC Health Care
- CXT Industrials
- Exchange
- CELC Nasdaq
- CXT Nasdaq
- Market Cap
- CELC 3.1B
- CXT 3.4B
- IPO Year
- CELC 2017
- CXT N/A
- Fundamental
- Price
- CELC $100.23
- CXT $56.86
- Analyst Decision
- CELC Strong Buy
- CXT Buy
- Analyst Count
- CELC 7
- CXT 3
- Target Price
- CELC $95.29
- CXT $75.00
- AVG Volume (30 Days)
- CELC 916.2K
- CXT 450.4K
- Earning Date
- CELC 11-12-2025
- CXT 11-05-2025
- Dividend Yield
- CELC N/A
- CXT 1.21%
- EPS Growth
- CELC N/A
- CXT N/A
- EPS
- CELC N/A
- CXT 2.68
- Revenue
- CELC N/A
- CXT $1,578,900,000.00
- Revenue This Year
- CELC N/A
- CXT $9.09
- Revenue Next Year
- CELC N/A
- CXT $7.64
- P/E Ratio
- CELC N/A
- CXT $21.00
- Revenue Growth
- CELC N/A
- CXT 9.30
- 52 Week Low
- CELC $7.58
- CXT $41.54
- 52 Week High
- CELC $103.06
- CXT $69.00
- Technical
- Relative Strength Index (RSI)
- CELC 78.25
- CXT 38.90
- Support Level
- CELC $92.10
- CXT $53.18
- Resistance Level
- CELC $103.06
- CXT $56.49
- Average True Range (ATR)
- CELC 5.52
- CXT 1.77
- MACD
- CELC 0.74
- CXT -0.30
- Stochastic Oscillator
- CELC 90.84
- CXT 35.83
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.